Inventor · disambiguated record
Hakon Leffler
Also filed as: LEFFLER HAKON
20 granted patents·7 pending applications·216 citations·filing 1981–2022
95Inventor score
Top patents by PatentIndex Score
27 records- 0196US11377464B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2020·Granted Jul 5, 2022·6 cites·27 claims
- 0293US9243021B2Galactoside inhibitor of galectinsUNIV EDINBURGH·Filed 2013·Granted Jan 26, 2016·15 cites·11 claims
- 0392US10988502B2Alpha-D-galactoside inhibitors of galectinsGALECTO BIOTECH AB·Filed 2017·Granted Apr 27, 2021·8 cites·24 claims
- 0491US7638623B2Galactoside inhibitors of galectinsFORSKARPATENT I SYD AB·Filed 2006·Granted Dec 29, 2009·41 cites·15 claims
- 0590US9688713B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2015·Granted Jun 27, 2017·4 cites·7 claims
- 0689US10526360B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2019·Granted Jan 7, 2020·7 cites·6 claims
- 0788US10774102B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2016·Granted Sep 15, 2020·7 cites·28 claims
- 0886US9580456B2Galactoside inhibitor of galectin-3 and its use for treating pulmonary fibrosisGALECTO BIOTECH AB·Filed 2013·Granted Feb 28, 2017·8 cites·19 claims
- 0986US7700763B23-triazolyl-galactoside inhibitors of galectinsFORSKARPATENT I SYD AB·Filed 2006·Granted Apr 20, 2010·19 cites·14 claims
- 1085US10253059B2Hybrid galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2015·Granted Apr 9, 2019·3 cites·22 claims
- 1185US8703720B2Galactoside inhibitors of galectinsLEFFLER HAKON·Filed 2010·Granted Apr 22, 2014·13 cites·19 claims
- 1285US6770622B2N-terminally truncated galectin-3 for use in treating cancerFiled 2001·Granted Aug 3, 2004·32 cites·2 claims
- 1382US10889610B2Alpha-D-galactoside inhibitors of galectinsGALECTO BIOTECH AB·Filed 2017·Granted Jan 12, 2021·4 cites·20 claims
- 1479US11919921B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2022·Granted Mar 5, 2024·0 cites·7 claims
- 1579US9353141B2Galectoside inhibitors of galectinsGALECTO BIOTECH AB·Filed 2013·Granted May 31, 2016·8 cites·19 claims
- 1677US7230096B2Inhibitors against galectinsNILSSON ULF·Filed 2002·Granted Jun 12, 2007·17 cites·8 claims
- 1773US10464964B2Galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2016·Granted Nov 5, 2019·2 cites·20 claims
- 1873US2019375776A1Idiopathic pulmonary fibrosis-detection, monitoring, prediction methodsGALECTO BIOTECH AB·Filed 2019·Application pending·0 cites
- 1971US2021221836A1Idiopathic pulmonary fibrosis-detection, monitoring, prediction methodsGALECTO BIOTECH AB·Filed 2021·Application pending·0 cites
- 2066US2017275326A1Idiopathic pulmonary fibrosis-detection, monitoring, prediction methodsGALECTO BIOTECH AB·Filed 2017·Application pending·0 cites
- 2157US4464360AGlycosphingalipids for inhibiting bacterial adherenceLEFFLER HAKON·Filed 1981·Granted Aug 7, 1984·22 cites·2 claims
- 2253US10800804B2Hybrid galactoside inhibitor of galectinsGALECTO BIOTECH AB·Filed 2018·Granted Oct 13, 2020·0 cites·20 claims
- 2350US2014200190A1Novel galactoside inhibitors of galectinsGALECTO BIOTECH AB·Filed 2014·Application pending·0 cites
- 2447US2005032673A1Sustained release N-terminally truncated galectin-3 and antibodies to galectin-3 carbohydrate ligands for use in treating diseaseFiled 2003·Application pending·0 cites
- 2540US2015320782A1Methods, compositions and kits for treating, modulating, or preventing ocular angiogenesis or fibrosis in a subject using a galectin protein inhibitorUNIV TUFTS·Filed 2015·Application pending·0 cites
- 2637US10730902B21,1 ′-sulfanediyl-di-beta-D-galactopyranosides as inhibitors of galectinsGALECTO BIOTECH AB·Filed 2016·Granted Aug 4, 2020·0 cites·20 claims
- 2729US2017095496A1Galactoside inhibitors for new usesGALECTO BIOTECH AB·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →